Skip to content

Clinical trials

Multiple Myeloma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: United Kingdom Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20033
20041
20053
20065
20074
20085
20098
20108
20117
201210
20136
201410
20159
20169
201717
201810
20198
20209
202115
202215
202311
202411
20254
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Recruiting43
Active, not recruiting31
Terminated16
Unknown status15
Withdrawn3
Not yet recruiting2
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC27
Celgene22
GlaxoSmithKline12
University of Leeds11
AbbVie10
Amgen8
Bristol-Myers Squibb7
Pfizer7
Regeneron Pharmaceuticals5
Sanofi5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma212
Recurrence37
Neoplasms, Plasma Cell25
Neoplasms22
Lymphoma, Non-Hodgkin12
Leukemia, Myeloid, Acute11
Lymphoma11
Leukemia, Lymphocytic, Chronic, B-Cell9
Leukemia8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.